One study in humans with biopsy-verified hepatic steatosis was presented in 2018 at the American Diabetes Association Scientific Session, reporting that fat infiltration may cause glucagon resistance regarding amino acid metabolism whereas the acute effect of glucagon on hepatic glucose production was preserved [108]. Here, GCG is linked to fatty liver disease.